Pattern and impact of hepatic adverse events encountered during immune checkpoint inhibitors – A territory‐wide cohort study

BACKGROUND: Immune checkpoint inhibitors (ICIs) are increasingly used in the treatment of cancers. We aimed to evaluate the incidence and prognostic impact of hepatic adverse events (AEs) in a territory‐wide cohort of patients who received ICIs. METHODS: Patients were identified from a territory‐wid...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Stephen Lam, Yip, Terry Cheuk‐Fung, Wong, Vincent Wai‐Sun, Tse, Yee‐Kit, Yuen, Becky Wing‐Yan, Luk, Hester Wing‐Sum, Lui, Rashid Nok‐Shun, Chan, Henry Lik‐Yuen, Mok, Tony Shu‐Kam, Wong, Grace Lai‐Hung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541136/
https://www.ncbi.nlm.nih.gov/pubmed/32780516
http://dx.doi.org/10.1002/cam4.3378

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541136/
https://www.ncbi.nlm.nih.gov/pubmed/32780516
http://dx.doi.org/10.1002/cam4.3378

Ejemplares similares